Shares of NicOx SA (OTCMKTS:NICXF) crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $4.82 and traded as low as $4.36. NicOx shares last traded at $4.36, with a volume of 500 shares changing hands.
Separately, Zacks Investment Research lowered NicOx from a “buy” rating to a “hold” rating in a research report on Friday, July 17th.
The stock has a 50-day moving average of $4.82 and a two-hundred day moving average of $4.59.
Nicox SA, an ophthalmic company, researches, develops, and markets therapies that target various ophthalmic conditions in France and internationally. The company's product pipeline includes VyzultaTM, an intraocular pressure-lowering treatment; and NCX 470, a nitric oxide (NO)-donating candidate to treat glaucoma, as well as stand-alone NO donors for specific applications in ophthalmic diseases.
See Also: Buyback
Receive News & Ratings for NicOx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NicOx and related companies with MarketBeat.com's FREE daily email newsletter.